Mechanisms of Action of Dorsal Root Ganglion Stimulation for Chronic Pain
Mechanisms of Action of Dorsal Root Ganglion Stimulation for Chronic Pain
批准号:
10199761
负责人:
Robert Dwight Graham
金额:
$3.12万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2022-04-30
关键词:
AffectAfferent NeuronsAlternative TherapiesAmericanAnalgesicsAnatomic ModelsAnatomyAutomobile DrivingBiological MarkersCellsCessation of lifeClinicalClinical DataClinical Decision Support SystemsComputer ModelsDataDiseaseDorsalElectrodesElectromyographyElectrophysiology (science)EnsureFDA approvedGangliaGoalsHealth Care CostsHistologicHistologyHumanImplantIndividualIntractable PainKnowledgeLeadLocationMagnetic Resonance ImagingMeasurementMeasuresMedicalMichiganModelingMuscleNeuronsOpioidOrthopedic SurgeryOutcomeOverdosePainPain MeasurementPaintParesthesiaPatient-Focused OutcomesPatientsPharmaceutical PreparationsPharmacologic SubstancePhysiologic pulsePhysiologicalPositioning AttributePostoperative PeriodPrevalenceProceduresPublic HealthRefractoryScanningSignal TransductionSocietiesSourceSpinal CordSpinal GangliaStimulusSubcellular AnatomySystemTechnologyTestingTherapeuticUnited StatesVariantVisualWidthX-Ray Computed Tomographyanalogbasebody mapchronic painclinical careclinical implementationclinical painconventional therapydesignexperimental studyfirst-in-humanhuman dataimplementation outcomesimprovedinsightinterpatient variabilityneurophysiologynew technologynovelopioid epidemicpain inhibitionpain reliefpredictive modelingrelating to nervous systemresponsetherapy outcometreatment optimization
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The goal of this study is to elucidate the mechanisms of action of dorsal root ganglion stimulation
(DRGS) for chronic pain. Chronic pain affects approximately 100 million Americans, and accounts for more
than 600 billion dollars in healthcare costs each year. DRGS is an FDA-approved neurostimulation therapy for
chronic pain that is refractory to conventional medical management. Although some patients receive sufficient
pain relief in response to DRGS, clinical outcomes are often inconsistent. This variation in pain relief across
patients may be due to poor understanding of the physiological mechanisms governing stimulation-induced
pain relief. Therefore, we seek to uncover these mechanisms to ultimately optimize DRGS and improve clinical
outcomes. This study is driven by previous computer modeling results from our lab showing that within
stimulation parameter ranges used clinically, DRGS is likely driving the activity of large myelinated sensory
neurons. In this proposed study, we will further investigate these mechanisms using computational models to
determine sources of interpatient variability in DRGS outcomes. Furthermore, we will validate these models
using clinical electrophysiological data, and inform the cellular anatomy of our models using histological data.
We hypothesize that electrode location will be the largest source of variability in DRGS outcomes, and that
positive DRGS outcomes will predict predominant activation of large myelinated sensory neurons. This project
aims to characterize the mechanisms of action of DRGS to improve the implementation and outcomes of the
therapy, and the models resulting from this project could be used to systematically design and test novel
stimulation technologies (e.g. electrode and waveform design).
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.jpain.2021.07.008
发表时间:
2022-03
期刊:
The journal of pain
影响因子:
--
作者:
[Graham RD, Sankarasubramanian V, Lempka SF]
通讯作者:
Lempka SF
海外基金